Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes AlloMap Registry Study: the Clinical Long-term Management and Outcomes of Heart Transplant Recipients With Regular Rejection Surveillance Including Use of AlloMap Gene-expression Profiling Testing

NCT01833195 is registered in ClinicalTrials.gov with CareDx as lead sponsor.

NCT NCT01833195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01833195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes AlloMap Registry Study: the Clinical Long-term Management and Outcomes of Heart Transplant Recipients With Regular Rejection Surveillance Including Use of AlloMap Gene-expression Profiling Testing
Lead sponsor
CareDx
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
February 29, 2020
Enrollment
2,444 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant failure, cardiac transplant rejection, heart diseases